B. Koe

发表

Neuroleptic activity of chiral trans-hexahydro-gamma-carbolines.

B. Dominy, R. Sarges, A. Weissman, 1986, Journal of medicinal chemistry.

Structure-activity relationship of quinazolinedione inhibitors of calcium-independent phosphodiesterase.

J. Lowe, D. Helweg, J. Chen, 1991, Journal of medicinal chemistry.

The pharmacology of para-chlorophenylalanine, a selective depletor of serotonin stores.

A. Weissman, B. Koe, 1968, Advances in pharmacology.

Effects of novel catechol ether imidazolidinones on calcium‐independent phosphodiesterase activity, [3H]rolipram binding, and reserpine‐induced hypothermia in mice

I. Williams, N. Saccomano, B. Koe, 1990 .

Dopamine receptor blockade by imidoline and its proposed active conformation.

B. Dominy, B. Koe, S. Koch, 1980, European journal of pharmacology.

Inhibition of rat brain tryptophan hydroxylation with p-chloroamphetamine.

B. Koe, R. Corkey, 1976, Biochemical pharmacology.

Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.

R. G. Browne, A. Weissman, W. M. Welch, 1983, The Journal of pharmacology and experimental therapeutics.

The isolation of carcinogenic and other polycyclic aromatic hydrocarbons from barnacles.

B. Koe, L. Zechmeister, 1952, Archives of Biochemistry and Biophysics.

Monoamine oxidase inhibitors antagonize the acceleration of brain dopamine synthesis induced by neuroleptic drugs in vivo: Implications for the treatment of tardive dyskinesia

B. Koe, 1975, Experientia.

Preclinical pharmacology of sertraline: a potent and specific inhibitor of serotonin reuptake.

B. Koe, 1990, The Journal of clinical psychiatry.

Pharmacology of sertraline: a review.

J. Heym, B. Koe, 1988, The Journal of clinical psychiatry.

Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain.

B. Koe, 1976, The Journal of pharmacology and experimental therapeutics.

A common mechanism of action for antidepressant drugs

B. Koe, 1983 .

Calcium-independent phosphodiesterase inhibitors as putative antidepressants: [3-(bicycloalkyloxy)-4-methoxyphenyl]-2-imidazolidinones.

N. Saccomano, D. Phillips, B. Koe, 1991, Journal of medicinal chemistry.

Neuroleptic activity in 5-aryltetrahydro-gamma-carbolines.

J. Plattner, A. Weissman, W. M. Welch, 1980, Journal of medicinal chemistry.

BIOCHEMICAL ASSESSMENT OF THE NEUROLEPTIC ACTIVITY OF MOLINDONE

B. Koe, 1979 .

4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants.

R. G. Browne, P. Seymour, R. Sarges, 1990, Journal of medicinal chemistry.

Nontricyclic antidepressant agents derived from cis- and trans-1-amino-4-aryltetralins.

R. Sarges, B. Koe, A. Kraska, 1984, Journal of medicinal chemistry.

4‐Amino(1,2,4)triazolo(4,3‐a)quinoxalines. A Novel Class of Potent Adenosine Receptor Antagonists and Potential Rapid‐Onset Antidepressants.

R. G. Browne, P. Seymour, R. Sarges, 1991 .

p-Chlorophenylalanine: a specific depletor of brain serotonin.

A. Weissman, B. Koe, 1966, The Journal of pharmacology and experimental therapeutics.

1-(2-Aminoethyl)-3-methyl-8,9-dihydropyrano[3,2-e]indole: a rotationally restricted phenolic analog of the neurotransmitter serotonin and agonist selective for serotonin (5-HT2-type) receptors.

J. Macor, S. Zorn, B. Koe, 1992, Journal of medicinal chemistry.

ISOLATION AND CHARACTERIZATION OF URINARY METABOLITES OF BENZQUINAMIDE AND BENZQUINAMIDE ALCOHOL.

B. Koe, R. Pinson, 1964, Journal of medicinal chemistry.

Enhancement of benzodiazepine binding by methaqualone and related quinazolinones

B. Koe, L. Lebel, S. Koch, 1986 .

GABA‐like Actions of Levonantradol

A. Weissman, B. Koe, JOAN P. Leader, 1981, Journal of clinical pharmacology.

PREPARATION AND ANTIBIOTIC PROPERTIES OF SOME PHOSPHINYLAMINOPENICILLANIC ACIDS AND PHOSPHINOTHIOYLAMINOPENICILLANIC ACIDS.

A. R. English, B. Koe, T. Seto, 1963, Journal of medicinal chemistry.

Antagonism of 5-hydroxytryptamine by benzquinamide

A. Scriabine, B. Koe, J. W. Constantine, 1966 .

Behavioral effects of L-α-methyltyrosine, an inhibitor of tyrosine hydroxylase

A. Weissman, B. Koe, 1965 .

Antiamphetamine effects following inhibition of tyrosine hydroxylase.

S. Tenen, A. Weissman, B. Koe, 1966, The Journal of pharmacology and experimental therapeutics.

Differential effects of the enantiomers of 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP) at dopamine receptor sites.

B. Koe, S. Koch, N. Bacopoulos, 1983, European journal of pharmacology.

The isolation of carcinogenic and other polycyclic aromatic hydrocarbons from barnacles. II. The goose barnacle (Mitella polymerus).

B. Koe, L. Zechmeister, 1952, Archives of biochemistry and biophysics.

Preparation and spectral characteristics of all trans- and a cis-phytofluene.

B. Koe, L. Zechmeister, 1953, Archives of biochemistry and biophysics.

Pa 150, PA 153, and PA 166: new polyene antifungal antibiotics.

F. Tanner, B. Koe, K. V. Rao, 1957, Antibiotics annual.

Dependence of m-fluorophenylalanine toxicity on phenylalanine hydroxylase activity.

A. Weissman, B. Koe, 1967, The Journal of pharmacology and experimental therapeutics.

Chapter 22. Drugs and Deterrence of Alcohol Consumption

A. Weissman, B. Koe, 1969 .

In vitro conversion of phytofluene and phytoene into carotenoid pigments.

B. Koe, L. Zechmeister, 1952, Archives of biochemistry and biophysics.

Chapter 5. Adaptive Changes in Central Nervous System Receptor Systems

B. Koe, F. J. Vinick, 1984 .

Enhancement of brain [3H]flunitrazepam binding and analgesic activity of synthetic cannabimimetics.

M. Johnson, L. Melvin, A. Weissman, 1985, European journal of pharmacology.

Levonantradol, a potent cannabinoid-related analgesic, antagonizes haloperidol-induced activation of striatal dopamine synthesis.

B. Koe, 1981, European journal of pharmacology.

Clinical‐pharmacological evaluation of p‐chlorophenylalanine: A new serotonin‐depleting agent

B. Koe, V. Y. Cremata, B. Kenneth Koe, 1966, Clinical pharmacology and therapeutics.

m-Fluorotyrosine convulsions and mortality: relationship to catecholamine and citrate metabolism.

A. Weissman, B. Koe, 1967, Journal of Pharmacology and Experimental Therapeutics.

Inhibiting Action of p-Chlorophenylalanine and α-Methyl-p-chlorophenylalanine on Liver Phenylalanine and Tryptophan Hydroxylase

B. Koe, 1967 .

A novel class of "GABAergic" agents: 1-aryl-3-(aminoalkylidene)oxindoles.

A. Weissman, H. Howard, B. Koe, 1989, Journal of medicinal chemistry.

Stepwise Dehydrogenation of the Colorless Polyenes Phytoene and Phytofluene with N-Bromosuccinimide to Carotenoid Pigments

B. Koe, L. Zechmeister, 1954 .

An instance of the occurrence of carcinogenic substances in certain barnacles.

M. Shimkin, B. Koe, L. Zechmeister, 1951, Science.

Neuroleptic activity of the 5-aryltetrahydro-gamma-carboline series. Conformational requirements for interaction with central dopamine receptors.

J. Plattner, A. Weissman, W. M. Welch, 1980, Molecular pharmacology.

5-[(3-nitropyrid-2-yl)amino]indoles: novel serotonin agonists with selectivity for the 5-HT1D receptor. Variation of the C3 substituent on the indole template leads to increased 5-HT1D receptor selectivity.

Anne W. Schmidt, J. Macor, K. Ryan, 1994, Journal of medicinal chemistry.

Sertraline, a selective inhibitor of serotonin uptake, induces subsensitivity of beta-adrenoceptor system of rat brain.

B. Koe, L. Lebel, M. G. Page, 1987, European journal of pharmacology.

Treatment with sertraline, a new serotonin uptake inhibitor, reduces voluntary ethanol consumption in rats.

K. Gill, Z. Amit, B. Koe, 1988, Alcohol.

(+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)-piperidine binding to σ receptors in mouse brain in vivo

B. Koe, L. Lebel, C. A. Burkhart, 1989 .

[3H]Ro 15-1788 binding to benzodiazepine receptors in mouse brain in vivo: marked enhancement by GABA agonists and other CNS drugs.

B K Koe, E Kondratas, L L Russo, 1987, European journal of pharmacology.

PA 132, a new antibiotic. I. Isolation and chemical properties.

B. Koe, W. D. Celmer, B. Sobin, 1956, Antibiotics annual.

Stereospecific and potent analgetic activity for nantradol--a structurally novel, cannabinoid-related analgetic.

M. Johnson, B. Koe, G. Milne, 1979, NIDA research monograph.

Sertraline potently displaces (+)-[3H]3-PPP binding to sigma sites in rat brain.

J. Heym, T. Seeger, B. Koe, 1989, European journal of pharmacology.

5-cyano-1-[3-(N-methylpyrrolidin-2R-ylmethyl)indol-5-yl] benzimidazole (CP-161,242): A potent, centrally active 5-HT1D receptor agonist and benzodiazepine partial agonist

Anne W. Schmidt, P. Seymour, J. Macor, 1995 .

Contrasting locomotor effects of catecholamine releasers and tyrosine hydroxylase inhibitors in MAO-inhibited mice

A. Weissman, B. Koe, 1967, Psychopharmacologia.

Contrasting effects of ethyl beta-carboline-3-carboxylate (beta CCE) and diazepam on cerebellar cyclic GMP content and antagonism of both effects by Ro 15-1788, a specific benzodiazepine receptor blocker.

B. Koe, L. Lebel, 1983, European journal of pharmacology.

Convulsions and elevation of tissue citric acid levels induced by 5-fluorotryptophan.

A. Weissman, B. Koe, 1966, Biochemical pharmacology.

Separation of alpha 1 adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compounds.

Anne W. Schmidt, B. Koe, C. Fox, 1991, Journal of medicinal chemistry.

CP-93,129: A Potent and Selective Agonist for the Serotonin (5-HT1B) Receptor and Rotationally Restricted Analog of RU-24,969

K. Ryan, J. Heym, B. Koe, 1991 .

3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one: A Potent and Selective Serotonin (5-HT1B) Agonist and Rotationally Restricted Phenolic Analogue of 5-Methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indole.

K. Ryan, J. Heym, B. Koe, 1991 .

Inhibiting action of n-butyraldoxime on ethanol metabolism and on natural ethanol preference of C57BL mice.

S. Tenen, B. Koe, 1970, The Journal of pharmacology and experimental therapeutics.

Characterization of [3H]CP‐96,501 as a Selective Radioligand for the Serotonin 5‐HT1B Receptor: Binding Studies in Rat Brain Membranes

J. Macor, B. Koe, L. Lebel, 1992, Journal of neurochemistry.

[3H] sertraline binding to rat brain membranes

W. M. Welch, B. Koe, L. Lebel, 2005, Psychopharmacology.

Oxindole N-Methyl-D-Aspartate (NMDA) antagonists

B. Koe, C. Fox, B. Chenard, 1993 .

Biochemical and behavioral studies of the 5‐HT1B receptor agonist, CP‐94,253

J. Macor, J. Heym, B. Koe, 1992 .

Enhancement of benzodiazepine binding by progabide (SL 76002) and SL 75102

B. Koe, 1983 .

Binding and uptake studies with [3H]CP‐93, 129, a radiolabeled selective 5‐HT1B receptor ligand

J. Macor, B. Koe, L. Lebel, 1992 .

Calcium-Independent Phosphodiesterase Inhibitors as Putative Antidepressants: (3-(Bicycloalkoxy)-4-methoxyphenyl)-2- imidazolidinones.

D. Helweg, N. Saccomano, D. Phillips, 1991 .

Some fluorescent substances contained in the marine "blood worm" (Thoracophelia mucronata).

D. L. Fox, B. Koe, L. Zechmeister, 1952, Archives of biochemistry and biophysics.